4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Achieve Life Sciences, Inc. (ACHV) operates in the Biotechnology industry and is headquartered in Bothell, United States with about 28 employees. Its market capitalization is roughly $626 million. In the fiscal year ended 2025-12-31, ACHV reported $0M in revenue and ($55M) in net income.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($55M) | ($39M) | ($27M) | ($41M) |
| Net Income | ($55M) | ($40M) | ($30M) | ($42M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($10M) | ($15M) | ($15M) | ($13M) | ($13M) | — |
| Net Income | ($10M) | ($15M) | ($14M) | ($13M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $42M | $39M | $19M | $30M | — |
| Total Liabilities | $20M | $18M | $21M | $22M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ACHV viewer.
About TickerBase · Data methodology & sources